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ntroduction
Staphylococcus aureus is amajor pathogen in dairy cattle
stitis (Waage et al., 1998; Tenhagen et al., 2006; Piepers
et al., 2007). Resistance of S. aureus to antimicrobial agents
can complicate treatment of its infections (Lowy, 2003).
For treatment of mastitis, methicillin resistance, which is
caused by the expression of themecA gene, is of particular
interest. Indeed, this mechanism confers resistance to
almost all types of b-lactam antibiotics active against
S. aureus, and these antibiotics are still frequently used
in mastitis treatment (Sawant et al., 2005). However,
methicillin-resistant Staphylococcus aureus (MRSA) has
never been important inmastitis. After the very ﬁrst report
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A B S T R A C T
Methicillin-resistant Staphylococcus aureus (MRSA) is infrequently reported in mastitis.
Yet, as in many other countries, the prevalence of methicillin resistance among S. aureus
from mastitis is currently unknown in Belgium.
To elucidate this, the presence of mecA was investigated in 118 S. aureus strains
originating from diagnosticmastitismilk samples from 118 different farms experiencing S.
aureus mastitis. MRSA strains were characterized by disk diffusion susceptibility testing,
spa-typing, MLST and SCCmec-typing. In an additional study, four MRSA-positive farms
were selected to assess the in-herd prevalence of MRSA, by sampling all cows in lactation.
Isolated MRSA strains were similarly characterized.
The mecA gene was detected in 11 (9.3%) of the 118 S. aureus isolates, indicating that
nearly 10% of the Belgian farms suffering from S. aureus mastitis have an MRSA problem.
The in-herd prevalence varied between 0% and 7.4%. Characterization of the MRSA strains
showed that they were all resistant to tetracycline. Additional resistances to macrolides,
lincosamides and aminoglycosides were frequently detected. The strains were ST398, spa-
types t011 or t567 and had SCCmec-type IVa or V, proving that they belong to the emerging
livestock-associated MRSA (LA-MRSA) strains of CC398.
Our study shows that after detection in Belgian pigs, horses and poultry, LA-MRSA has
also attained Belgian cattle. It is the ﬁrst report on frequent isolation of LA-MRSA from
bovine infections. As the in-herd isolation rate resembles that of regular S. aureus in farms
experiencing S. aureusmastitis, the multi-resistance of LA-MRSA strains may cause future
treatment problems.
 2010 Elsevier B.V. All rights reserved.
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VETMIC-4743; No of Pages 6of MRSA in mastitis in 1972 (Devriese et al., 1972), MRSA
has been described inmastitis only occasionally (Lee, 2003,
2006; Kwon et al., 2005; Juha´sz-Kaszanyitzky et al., 2007;
Moon et al., 2007; Hendriksen et al., 2008). From such
studies, it seems that the prevalence of MRSA in mastitis is
generally low. Yet, data on MRSA in mastitis need to be
assessed carefully, as there are often ambiguities in the
presence of mecA, level of investigation and origin of the
detected MRSA strains.
Recently, a speciﬁc MRSA clone, CC398, has been found
to be associated with pigs, veal calves, broiler chickens,
companion animals and people in close contact with
livestock. MRSA of this type, called livestock-associated
MRSA (LA-MRSA), typically has closely related spa-types
(de Neeling et al., 2007; Denis et al., 2009), carries mostly
SCCmec-types IVa and V (Witte et al., 2007; Van Den Eede
et al., 2009) and cannot be typed with PFGE using SmaI
digestion (Bens et al., 2006). In addition, LA-MRSA shows
resistance against tetracycline and, to a lesser extent,
macrolides, lincosamides, aminoglycosides and ﬂuoroqui-
nolones (Witte et al., 2007). Generally LA-MRSA lacks
common virulence factors found in other MRSA (Monecke
et al., 2007; Walther et al., 2009). This is remarkable
because, although infrequently compared to colonization,
LA-MRSA has been isolated from infections, of both
animals and humans (e.g. Hermans et al., 2008; Krziwanek
et al., 2009). To our knowledge, so far only one study has
reported on the isolation of MRSA ST398 from a case of
mastitis (Monecke et al., 2007).
We performed two studies to assess the role of MRSA in
Belgian S. aureusmastitis. In the ﬁrst studywe investigated
how many S. aureus isolated from mastitis were resistant
to methicillin. Second, we investigated the in-herd
prevalence of MRSA in Belgian herds where cows were
previously shown to suffer from MRSA mastitis.
2. Methods
2.1. Methicillin resistance in S. aureus isolated from mastitis
2.1.1. Strains
From November 2006 through April 2007, the regional
veterinary laboratories were asked to send us a repre-
sentative isolate from all farms on which an S. aureus-
mastitis problem was detected. Care was taken to include
only one strain per visited farm. As such, a collection of 118
non-duplicate isolates of S. aureus, originating from cases
of subclinical or clinical mastitis from different farms were
obtained.
2.1.2. DNA extraction
An Eppendorf cup (Eppendorf, Germany) containing a
500mL Brain Heart Infusion (BHI) broth (BioRad, France)
overnight pure culture was centrifuged for 3.0min at
approx. 20,000 g, at room temperature. After the removal
of the supernatant, 45mL of sterile, distilled water and
5mL of a 1mg/mL lysostaphin (Sigma–Aldrich, USA)
solution at 4 8C were thoroughly mixed with the pellet
of cells. After incubation for 10min at 37 8C, 45mL of
sterile, distilled water, 5mL of a 2mg/mL proteı¨nase K
of 0.1M at pH 8.0 were added. The resulting solution was
incubated for 10min at 60 8C, followed by 5min at 100 8C
and then centrifuged for 5min at approx. 20,000 g, at
room temperature. DNA was stored at 20 8C until use.
2.1.3. Identiﬁcation of MRSA
A triplex PCR, targeting a Staphylococcus-speciﬁc 16S
rRNA sequence, the mecA gene and the S. aureus-speciﬁc
region of the thermonuclease gene (nuc), was performed as
previously described (Maes et al., 2002). The ampliﬁed
DNA fragments were separated by electrophoresis on a 2%
agarose (Sigma–Aldrich, USA) gel stained with SYBR Safe
DNA gel stain (Invitrogen, USA), for 2 h at 80 V, using an
O’RangeRuler 100 bp DNA ladder (Fermentas, Germany).
2.1.4. Characterization of MRSA
2.1.4.1. Susceptibility testing. Strains proven to be MRSA
were tested for susceptibility to non-b-lactam antimicro-
bial agents, by using the disk diffusion method. A panel of
16 antimicrobial agents were used: chloramphenicol,
gentamicin, kanamycin, tobramycin, fucidic acid, erythro-
mycin, tylosin, lincomycin, linezolid, quinupristin + dalfo-
pristin, mupirocin, ciproﬂoxacin, tetracycline, rifampicin,
sulfonamides and trimethoprim (NeoSensitabs, Rosco,
Denmark). Results were recorded after 24 h incubation
at 37 8C and interpreted according to the directions for use
of Rosco with the method described by the CLSI guidelines
(document M31-A3).
2.1.4.2. Spa-typing. Of all MRSA strains, the polymorphic
X-region of the Staphylococcus protein A (spa) gene was
ampliﬁed according to the Ridom StaphType standard
protocol (www.ridom.de/staphtype). Amplicons were
puriﬁed with a Nucleospin Extract II kit (Macherey-Nagel,
Germany) and then sequenced using the sameprimers. The
sequenced DNA was then run on a CEQ 8000 Genetic
Analysis System (Beckman Coulter, United Kingdom)
according to themanufacturer’s instructions. The resulting
spa-types were assigned by using the Ridom StaphType
software package (Ridom GmbH, Germany).
2.1.4.3. MLST. Multi-Locus Sequence Typing was per-
formed on all MRSA strains. In short, seven household
genes of S. aureuswere ampliﬁed using primers previously
described (Enright et al., 2000). Amplicons were puriﬁed
with a Nucleospin Extract II kit (Macherey-Nagel, Ger-
many) and then sequenced using the same primers. The
sequenced DNA was then run on a CEQ 8000 Genetic
Analysis System (Beckman Coulter, United Kingdom)
according to the manufacturer’s instructions. Allele
numbers and sequence type (ST) were assigned by using
the S. aureus MLST website (http://saureus.mlst.net).
2.1.4.4. SCCmec-typing. The SCCmec-type was determined
using three different sets of primers (Oliveira and de
Lencastre, 2002; Zhang et al., 2005; Milheiric¸o et al., 2007).
For differentiation among SCCmec-types I–IV we used all
the primers described by Oliveira and de Lencastre (2002).
The PCR mix consisted of 25mL of Taq PCR Master Mix
(Qiagen GmbH, Germany), 4mL of H2O and 16mL of the(Merck, Germany) solution at 4 8C and 150mL of Tris–HClPlease cite this article in press as: Vanderhaeghen, W., et al., Methicillin-resistant Staphylococcus aureus (MRSA) ST398
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mers, in the reported concentration. To this mix 5mL
A was added.
For subtyping SCCmec of type IV, we used the primers
cribed by Milheiric¸o et al. (2007). The PCR-mix
sisted of 25mL of Taq PCR Master Mix (Qiagen GmbH,
many), 6.4mL of H2O, 0.2mM of primers J IVa forward
and reverse (R), 0.2mMof J IVb F and R, 0.4mMof ccr B2
d J IVc F and R, 0.8mM of ccrB2 R, J IVd F and R, 0.9mM
IVg F and R, and 0.9mMof J IVh F and R. To themix 5mL
A was added.
A third set, meant to detect SCCmec-type V and to have
ntrol for SCCmec-types IVb, IVc, IVe and IVf, was based
the method described by Zhang et al. (2005). The PCR
consisted of 25mL of Taq PCR Master Mix (Qiagen
bH, Germany), 10.4mL of H2O, 0.6mM of primers Type
and R, 0.8mM of Type IVc F and R, and 1.0mM of Type
F and R. To the mix 5mL DNA was added.
We used the same PCR program for all the three sets: an
ial denaturation of 4min at 94 8C, 35 cycles of
aturation at 94 8C for 30 s, annealing at 53 8C for 30 s
extension at 72 8C for 1min, followed by a ﬁnal
ension for 4min at 72 8C.
MRSA in-herd prevalence
From the results of the ﬁrst study, four MRSA-positive
s were selected for investigation of the in-herd
valence of MRSA, deﬁned as the number of MRSA-
itive cows relative to the total number of lactating
s present in the speciﬁc farm. A randomly chosen ﬁfth
volunteered to serve as control (Table 2). Milk
pleswere taken fromeachquarter. All samplingswere
e by the same person, from February 2008 through
il 2008.
Samples were immediately transported to the Veter-
ry and Agrochemical Research Center (VAR), where
h sample was plated on Columbia Colistine Aztreonam
tes (CAP) supplemented with 5% sheep blood (Oxoid,
many) and on chromID MRSA plates (Biome´rieux,
nce). Suspected S. aureus or MRSA colonies were
iﬁed. Pure colonies were then subjected to the MRSA
lex PCR, as described above. Strains identiﬁed as MRSA
re characterized by susceptibility testing, spa-typing,
ST and SCCmec-typing, as described above.
3. Results
3.1. Methicillin resistance in S. aureus isolated from mastitis
3.1.1. Detection of MRSA
All 118 isolates phenotypically identiﬁed as S. aureus
were conﬁrmed to be S. aureus by the triplex PCR. A total of
11 isolates (9.3%) contained mecA (Table 1). Two MRSA
originated from clinical mastitis, the other nine from
subclinical mastitis (Table 1).
3.1.2. Antimicrobial susceptibility testing
Antibiotic resistance patterns of the 11 MRSA strains
are shown in Table 1. Nine of them showed additional
resistance to at least two different antibiotics. All strains
were resistant to tetracycline; nine were resistant to
trimethoprim, seven to aminoglycosides and lincomycin,
ﬁve to macrolides and two to ciproﬂoxacin (Table 1). No
resistance was detected to the other antimicrobial agents
tested.
3.1.3. MLST, spa- and SCCmec-typing
Ten strains were spa-type t011. One strain had a
different yet related spa-type, t567 (Table 1). All MRSA
strains were ST398 (Table 1). Five strains had SCCmec-type
IVa, and ﬁve had SCCmec-type V. The SCCmec-type of one
strain could not be determined with the different sets of
primers we used (Table 1).
3.2. MRSA in-herd prevalence
3.2.1. Identiﬁcation of MRSA
The percentage of cows carrying MRSA in their milk
varied between 0% and 7.4% (Table 2). Quarter level
prevalence ranged from 0% to 1.98% (Table 2). Three of the
four selected farms were positive. MRSA could not be
detected in one farm previously found positive nor in the
control farm (Table 2).
One cow from the ﬁrst farm carried MRSA in three of
her quarters. In all other positive cows, MRSA was found
in only one quarter, resulting in 14 isolates in total
(Table 3). Most isolates were found in the right-hind (six
isolates) and right-front (four isolates) quarter (Table 3).
Of the 11 cows that had MRSA in only one quarter, nine
le 1
stance proﬁle, Multi-Locus Sequence Type (MLST), spa- and Staphylococcal Cassette Chromosome (SCC)mec-type per MRSA strain in study 1.
rain Type of mastitis Resistance proﬁlea spa MLST SCCmecb
Subclinical AG, TET, TMP t011 398 IVa
Clinical AG, TET, TMP t011 398 IVa
Subclinical AG, ML, LM, TET, TMP t011 398 IVa
Subclinical LM, CIP, TET, TMP t011 398 V
Subclinical TET t567 398 NT
Subclinical AG, ML, LM, TET, TMP t011 398 IVa
Subclinical LM, CIP, TET, TMP t011 398 V
Clinical AG, ML, LM, TET, TMP t011 398 IVa
Subclinical KAN, TOB, ML, LM, TET, TMP t011 398 V
Subclinical AG, ML, LM, TET, TMP t011 398 V
Subclinical TET t011 398 V
AG: all aminoglycosides tested; KAN: kanamycin; TOB: tobramycin; ML: all macrolides tested; LM: lincomycin; CIP: ciproﬂoxacin; TET: tetracycline;: trimethoprim.
NT: not typeable with the primers used.
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quarters.
3.2.2. Antimicrobial susceptibility testing
All six strains isolated from the ﬁrst farm had the
same susceptibility proﬁle (Table 3). They were all
resistant to tetracycline, the tested macrolides and
lincomycin, and were susceptible to all other antimi-
crobial agents tested.
In the second farm, two out of ﬁve strainswere resistant
to trimethoprim, tetracycline and the tested aminoglyco-
sides, and susceptible to all other antimicrobial agents
tested. The three other strains had additional resistances to
the tested macrolides and lincomycin (Table 3).
The three strains from the third farm were resistant to
the tested aminoglycosides, macrolides, lincomycin, tetra-
cycline and trimethoprim (Table 3). They were susceptible
to the other antimicrobial agents tested.
3.2.3. MLST, spa- and SCCmec-typing
All MRSA strains showed spa-type t011 (Table 3). The
strains originating from the ﬁrst farm had SCCmec-type
V, while all strains isolated from the cows of the other
two farms had SCCmec-type IVa (Table 3). MLST was
performed on one representative MRSA strain per farm.
As strains from farm 2 showed two different resistance
proﬁles, one representative strain from each proﬁle was
tested. All the four strains tested were ST398 (Table 3).
4. Discussion
The prevalence of methicillin resistance in S. aureus
isolated from mastitis in our ﬁrst study is unexpectedly
high. In the abundance of studies investigating the
antibiotic resistance of mastitis pathogens, few reports
have noted a substantial occurrence of methicillin
resistance, meaning MRSA is usually negligible as a
mastitis pathogen (Hendriksen et al., 2008). However,
we found nearly 10% of our 118 S. aureus strains to be
MRSA. This means that nearly 10% of the Belgian farms
experiencing S. aureus mastitis are affected by MRSA.
Reports can be found in which a higher prevalence of
MRSA among S. aureus isolated from mastitis cases is
described. In Turkey, Turutoglu et al. (2006) found 18 out
of 103 (17.5%) S. aureus isolates from mastitis milk
samples to be MRSA. However, they did not mention
whether all strains were collected from different farms
experiencing S. aureus mastitis. In addition, their detec-
tion method was limited to phenotypic disk diffusion
testing. Performing only phenotypic tests has previously
been shown to lead to false positive or false negative
results (Murakami et al., 1991; De Oliveira et al., 1999).
Generally it is now accepted that checking for the
presence of mecA is the most reliable method for the
detection of methicillin resistance, and staphylococci
carryingmecA should be regarded as resistant to almost all
types of b-lactam antibiotics (CLSI guidelines, M31-A3).
Consequently, to accurately assess our results, only other
reports in whichmecAwas proven to be present should be
considered. Still, even then, it remains difﬁcult to make
viable comparisons, due to differences in sampling
methodology or a lack of information on the source of
the strains. For example, two South Korean studies did not
mention exactly how many of their samples originated
from mastitis (Lee, 2003, 2006). A Hungarian study
sampled only a single farm (Juha´sz-Kaszanyitzky et al.,
2007). In two other studies from South Korea, the data
involved quarter level results (Kwon et al., 2005; Moon et
al., 2007).
Table 3
Resistance proﬁle, Multi-Locus Sequence Type (MLST), spa- and Staphylococcal Cassette Chromosome (SCC)mec-type per MRSA strain in study 2.
Farm Quartera Strain Resistance proﬁleb Spa MLSTc SCCmec
1 LH 1 ML, LM, TET t011 ND V
RH 2 ML, LM, TET t011 ND V
RF 3 ML, LM, TET t011 ND V
LF 4 ML, LM, TET t011 398 V
RH 5 ML, LM, TET t011 ND V
RF 6 ML, LM, TET t011 ND V
2 LH 7 AG, TET, TMP t011 398 IVa
LF 8 AG, ML, LM, TET, TMP t011 ND IVa
RH 9 AG, TET, TMP t011 ND IVa
RH 10 AG, ML, LM, TET, TMP t011 398 IVa
RH 11 AG, ML, LM, TET, TMP t011 ND IVa
3 RH 12 AG, ML, LM, TET, TMP t011 ND IVa
RH 13 AG, ML, LM, TET, TMP t011 ND IVa
RF 14 AG, ML, LM, TET, TMP t011 398 IVa
a LF: left-front; LH: left-hind; RH: right-hind; RF: right-front.
b AG: all aminoglycosides tested; LM: lincomycin; ML: all macrolides tested; TET: tetracycline; TMP: trimethoprim.
Table 2
In-herd prevalence of MRSA.
Farma Herd size
(n cows)
Herd size
(n quarters)
Positive
cows
Positive
quarters
n % n %
1 63 252 4 6.3 6 1.98
2 68 272 5 7.4 5 1.83
3 77 308 3 3.9 3 0.97
4 51 204 0 0 0 0
5 69 276 0 0 0 0
a No. 5: control farm.c ND: not determined.
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mDespite these difﬁculties to fully assess our results, it
st be acknowledged that the MRSA prevalence we
nd is quite high. However, some other remarks should
made. First, the burden of MRSA for Belgian milk
duction cannot be assessed, because we have no data
the total number of farms that were visited during the
pling period. Also, while our study allows us to
mate the importance of methicillin resistance in
gian S. aureusmastitis, we cannot judge the importance
RSA for mastitis as a whole. A hint to address the latter
be found in a recent study that investigated the
ortance of S. aureus in Belgian mastitis. It was found
t S. aureus was the most prevalent species in Belgian
rtermilk samples from subclinicalmastitis, with 25% of
ture-positive quarter samples with a geometric mean
posite somatic cell count of250,000 cells/mL harbor-
S. aureus (Piepers et al., 2007). Regarding this, our result
ertainly quite worrying.
Another important fact is presented by our typing data.
our strains had characteristics typical for the emerging
stock-associated MRSA CC398 strains. Consequently, it
ms that our ﬁndings should rather be regarded as a
her expansion of the host range of the CC398 MRSA
e than as an indication of a generally increasing
idence of methicillin resistance in mastitis-associated S.
eus. This should however not be less worrying.
In addition to its resistance against all b-lactam
ibiotics, which are still the most used antimicrobial
nts in the treatment of mastitis, the typical antibiotic
istances of LA-MRSA also include some other antibiotics
d to treat or prevent mastitis, such as aminoglycosides
macrolides (Sawant et al., 2005). This could lead to
ious treatment problems. Moreover, in our second
dy we found that the in-herd prevalence of LA-MRSA
ged between 0% and 7.4%. In the farmswhereMRSAwas
nd, it varied from 3.9% to 7.4%, with a corresponding
rter level prevalence of 0.97–1.98%. This resembles the
erd quarter level prevalence of S. aureus described
lier in a cross-sectional collection of Belgian milk
ples (Piepers et al., 2007), suggesting that, considering
spread in farms, LA-MRSA behaves similar to regular
stitis causing S. aureus. The possibility that LA-MRSA
ld become equally important in mastitis as normal S.
eus should thus be thoroughly investigated. Unfortu-
ely, we have no data on the individual health status of
cows from which MRSA was isolated in our second
dy, so we cannot state that the LA-MRSA strains we
nd were actually involved in mastitis. As it was shown
t within-cow transmission between quarters likely
urs in S. aureusmastitis (Barkema et al., 1997), the fact
t 11 of the 12 cows carried LA-MRSA in only one quarter
ldmean that the isolates concerned only contaminants.
ever, S. aureus infection of only one quarter also
tainly exists (Barkema et al., 1997). Moreover, S. aureus
s shown to more frequently infect the right and hind
rters (Barkema et al., 1997, 2006). Of the 11 single-
rter LA-MRSA isolates we found, 10 originated from
t quarters and nine from hind quarters. Considering
our ﬁrst study, which clearly showed the capacity of
MRSA to cause mastitis, the actual presence of LA-
more depth, in order to profoundly assess its possible
burden.
LA-MRSAhas been reported only once before inmastitis
in cows, one LA-MRSA strain that was found among 128 S.
aureus isolated from German mastitis cases (Monecke et
al., 2007). While this strain was spa-type t034, our strains
were spa-types t011 and t567. It thus seems unlikely that a
speciﬁc subclone of LA-MRSA is associated with mastitis,
but more research is required to conﬁrm this. Until now, it
is also unclear whether LA-MRSA has an actual reservoir in
dairy cattle. Whereas veal calves have been found carrying
LA-MRSA in the Netherlands (Mooij et al., 2007) and
Belgium (unpublished data), the colonization capacity of
LA-MRSA in milking cows has not yet been investigated.
The presence of LA-MRSA in infectionshas been reported
substantially less frequent than carriage, and has only been
described occasionally in pigs (van Duijkeren et al., 2007),
horses (Hermans et al., 2008; Loefﬂer et al., 2009), humans
(e.g. Krziwanek et al., 2009) and a dog (Witte et al., 2007).
Our ﬁndings thus seem to add new proof of a certain
pathogenic potential of LA-MRSA. Remarkably, many
common virulence factors, including those considered to
be involved inmastitis, such as toxic shock syndrome toxin-
1 (TSST-1), haemolysins and enterotoxins (Matsunaga et al.,
1993), have been shown to be largely absent in LA-MRSA
(Monecke et al., 2007;Walther et al., 2009). However, as we
did not check for the presence of virulence factors in our
strains, the signiﬁcanceofourdata regarding thepathogenic
potential of LA-MRSA is hard to assess. Yet, in addition to the
other reports on LA-MRSA associated with infections, our
ﬁndings urge for further research into the virulence
capacities of LA-MRSA.
5. Conclusions
We found an unusual high prevalence of MRSA in
Belgian cases of subclinical and clinical S. aureusmastitis in
cows. All strains belonged to the CC398 clone, which, seen
its multi-resistance, may lead to treatment problems.
Future research is warranted to assess the actual spread
and corresponding burden that LA-MRSA may pose for
dairy cattle farming and to elucidate which virulence
factors are involved.
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